@therestoreclinic's TRT fertility claims need context

What did @therestoreclinic actually say?

The creator, apparently a clinician, claims he personally fathered a child while on TRT, and that many of his patients have done the same. His core argument: testosterone "does and can have a suppressive effect on your sperm production" but does not guarantee infertility. He then walks through a protocol hierarchy, starting with HCG as an LH-mimetic, then adding FSH (urofolltropin), then mentioning menotropins (he calls it "minipure"), and finally clomiphene or tamoxifen as SERMs. He names HCG plus FSH as "the gold standard" from his clinical experience.

The video is framed as a reply to a follower question, which gives it an informal, reassuring tone. That informality is part of what needs scrutiny here. Personal anecdote does not equal evidence of efficacy, and a protocol list with no safety framing is the kind of content that gets men self-medicating without proper workup.

Does the science back this up?

On the core biology, yes, largely. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing LH and FSH, which tanks intratesticular testosterone and spermatogenesis. But "suppresses" is not the same as "eliminates," and the degree of suppression varies by individual, dose, and duration.

The HCG-as-LH-mimetic mechanism is accurate. HCG binds to LH receptors on Leydig cells, stimulates intratesticular testosterone production, and this in turn supports Sertoli cell function and sperm production. A 2009 study by Coviello et al. in the Journal of Clinical Endocrinology and Metabolism showed that HCG co-administration with testosterone maintained intratesticular testosterone concentrations, which exogenous testosterone alone significantly depleted.

The claim about combining HCG with recombinant FSH also has support. Ramasamy et al. (2015, Journal of Urology) found that men with hypogonadotropic hypogonadism who failed HCG monotherapy achieved sperm production when FSH was added. That supports the HCG-plus-FSH claim, though most of that data comes from men with secondary hypogonadism, not men who are simply suppressed from exogenous TRT use.

What did they get wrong (or right)?

The creator gets the mechanism right and the protocol hierarchy is clinically reasonable. Credit where it is due. But a few things are oversimplified or missing entirely.

First, he calls HCG plus FSH "the gold standard" based on what he has "seen clinically." That is not how gold standards get established. The literature on fertility restoration during or after TRT is still relatively thin, and most controlled data comes from hypogonadotropic hypogonadism populations, not general TRT users. Extrapolating that to all TRT patients is a stretch.

Second, there is no mention of azoospermia risk. For some men, especially those on high-dose testosterone for extended periods, sperm suppression can be severe or prolonged. Recovery of spermatogenesis after TRT cessation can take 6 to 18 months, and in some cases it does not fully recover. Liu et al. (2006, Journal of Clinical Endocrinology and Metabolism) documented this in the context of hormonal contraception research.

Third, the SERM section is underdeveloped. Clomiphene and tamoxifen work by blocking estrogen feedback at the hypothalamus and pituitary, stimulating endogenous LH and FSH. They are not interchangeable with HCG in mechanism, and they are not typically used while someone remains on exogenous testosterone, because exogenous testosterone bypasses the HPG axis entirely. Using SERMs while actively on TRT has limited logical basis unless TRT is being tapered or discontinued.

What should you actually know?

If you are on TRT and want to preserve or restore fertility, do not take protocol cues from a TikTok video, even one from a clinician. The right move is a semen analysis before and during treatment, a conversation with a reproductive endocrinologist or urologist, and a clear plan documented in your chart.

HCG is a legitimate tool. So is recombinant FSH. But the FDA's compounded HCG landscape shifted significantly in 2020 when the FDA removed HCG from the list of bulk substances for compounding, which complicated access at many clinics. Patients should verify what formulation they are being prescribed and whether it is an FDA-approved product or a compounded version. Those are not equivalent and should not be treated as such.

The anecdote about fathering a child on TRT is not evidence that most men can do the same. Individual variation in sperm suppression is real. A baseline semen analysis is the only way to know where you actually stand.

• Exogenous testosterone reliably suppresses spermatogenesis but the degree varies significantly between individuals.
• HCG co-administration can maintain intratesticular testosterone, supporting sperm production during TRT.
• Adding recombinant FSH to HCG has evidence in secondary hypogonadism populations, but data in TRT-suppressed men specifically is more limited.
• SERMs like clomiphene have limited utility while exogenous testosterone is still being administered, since they rely on an intact HPG axis response.
• Any man on TRT who wants to conceive should get a semen analysis and consult a reproductive specialist, not adjust protocols based on social media.